Patents by Inventor Mingcan Xia

Mingcan Xia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210278418
    Abstract: Described herein are methods and compositions for treating asthma or an allergic disease. Aspects of the invention relate to administering to a subject an agent that targets Notch4. In one embodiment, the agent is an anti-Notch4 antibody.
    Type: Application
    Filed: March 15, 2019
    Publication date: September 9, 2021
    Applicant: THE CHIDLREN'S MEDICAL CENTER CORPORATION
    Inventors: Talal Amine CHATILA, Hani HARB, Mingcan XIA, Amir MASSOUD
  • Patent number: 10588941
    Abstract: The invention provides compositions and methods for targeting CCR10 and/or the CCR10/ligand axis to modulate the immune response in a subject.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: March 17, 2020
    Assignee: THE PENN STATE RESEARCH FOUNDATION
    Inventors: Na Xiong, Mingcan Xia
  • Publication number: 20180327754
    Abstract: The invention provides compositions and methods for targeting CCR10 and/or the CCR10/ligand axis to modulate the immune response in a subject.
    Type: Application
    Filed: July 20, 2018
    Publication date: November 15, 2018
    Inventors: Na Xiong, Mingcan Xia
  • Patent number: 10053695
    Abstract: The invention provides compositions and methods for targeting CCR10 and/or the CCR10/ligand axis to modulate the immune response in a subject.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: August 21, 2018
    Assignee: THE PENN STATE RESEARCH FOUNDATION
    Inventors: Na Xiong, Mingcan Xia
  • Publication number: 20150376281
    Abstract: The present invention provides methods, compositions and kits for treating and detecting type 2 diabetes and/or conditions that may be regulated or normalised via inhibition of NKG2D, such as cardiovascular diseases.
    Type: Application
    Filed: September 10, 2015
    Publication date: December 31, 2015
    Inventors: Na Xiong, Mingcan Xia, David H. Raulet, Jacob Sten Petersen, Thora Brynja Bodvarsdottir
  • Publication number: 20150273054
    Abstract: The invention provides compositions and methods for targeting CCR10 and/or the CCR10/ligand axis to modulate the immune response in a subject.
    Type: Application
    Filed: March 26, 2015
    Publication date: October 1, 2015
    Inventors: Na Xiong, Mingcan Xia
  • Publication number: 20120148581
    Abstract: The present invention provides methods, compositions and kits for treating and detecting type 2 diabetes and/or conditions that may be regulated or normalised via inhibition of NKG2D, such as cardiovascular diseases.
    Type: Application
    Filed: August 16, 2010
    Publication date: June 14, 2012
    Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE PENN STATE RESEARCH FOUNDATION
    Inventors: Na Xiong, Mingcan Xia, David H. Raulet, Jacob Sten Petersen, Thora Brynja Bodvarsdottir